Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.181
Filtrar
1.
Acta Microbiol Immunol Hung ; 71(3): 191-196, 2024 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-39088273

RESUMEN

The aim of this study is to evaluate the antimicrobial susceptibility of invasive isolates of Serratia marcescens, associated with blood stream infections (BSIs) in patients hospitalized in Varna University Hospital, Bulgaria, as well as to identify the genetic mechanisms responsible for 3rd generation cephalosporin and carbapenem-resistance among these isolates. A total of 45 consecutive S. marcescens isolates, obtained from blood cultures of 45 patients with BSIs, hospitalized during an 8-year period (2016-2023) were included. Species identification and antimicrobial susceptibility testing were done by Phoenix (BD, USA) and Vitek 2 (BioMerieux, France) systems and the results were interpreted according to EUCAST guidelines. The genetic mechanisms of beta-lactam resistance were studied by PCR. During the study period, a total of 45 patients were diagnosed with S. marcescens-associated BSIs. All infections were defined as nosocomial, predominantly intensive care unit-acquired (42.2%) and 28.8% were central venous catheter-associated. The following antimicrobial resistance rates were found: ceftriaxone, piperacillin/tazobactam, 57.8%; ceftazidime, 55.6%; cefepime, trimethoprime/sulfamethoxazole, 53.3%; gentamicin, 48.8%; ciprofloxacin, 44.5%; amikacin, 15.6%; carbapenems, 2.2%. The blaCTX-M was identified in 88.9% of the tested 3rd generation cephalosporin resistant isolates. Among these, 50% were also blaTEM positive. The single carbapenem-resistant isolate harboured blaKPC, blaCTX-M1/9, blaCMY-2 and blaTEM. This study demonstrates S. marcescens as a problematic nosocomial pathogen and we report a KPC-producing S. marcescens clinical isolate from a BSI in Bulgaria.


Asunto(s)
Antibacterianos , Hospitales Universitarios , Pruebas de Sensibilidad Microbiana , Infecciones por Serratia , Serratia marcescens , Humanos , Bulgaria/epidemiología , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Serratia marcescens/aislamiento & purificación , Hospitales Universitarios/estadística & datos numéricos , Infecciones por Serratia/microbiología , Infecciones por Serratia/epidemiología , Antibacterianos/farmacología , Masculino , Femenino , Persona de Mediana Edad , Anciano , Infección Hospitalaria/microbiología , Infección Hospitalaria/epidemiología , Adulto , Bacteriemia/microbiología , Bacteriemia/epidemiología , Farmacorresistencia Bacteriana , Anciano de 80 o más Años
2.
Nat Commun ; 15(1): 6024, 2024 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-39019886

RESUMEN

Respiratory pathogens, commonly colonizing nasopharynx, are among the leading causes of death due to antimicrobial resistance. Yet, antibiotic resistance determinants within nasopharyngeal microbial communities remain poorly understood. In this prospective cohort study, we investigate the nasopharynx resistome development in preterm infants, assess early antibiotic impact on its trajectory, and explore its association with clinical covariates using shotgun metagenomics. Our findings reveal widespread nasopharyngeal carriage of antibiotic resistance genes (ARGs) with resistomes undergoing transient changes, including increased ARG diversity, abundance, and composition alterations due to early antibiotic exposure. ARGs associated with the critical nosocomial pathogen Serratia marcescens persist up to 8-10 months of age, representing a long-lasting hospitalization signature. The nasopharyngeal resistome strongly correlates with microbiome composition, with inter-individual differences and postnatal age explaining most of the variation. Our report on the collateral effects of antibiotics and prolonged hospitalization underscores the urgency of further studies focused on this relatively unexplored reservoir of pathogens and ARGs.


Asunto(s)
Antibacterianos , Hospitalización , Recien Nacido Prematuro , Nasofaringe , Humanos , Nasofaringe/microbiología , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Recién Nacido , Estudios Prospectivos , Femenino , Masculino , Metagenómica/métodos , Lactante , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Microbiota/efectos de los fármacos , Microbiota/genética , Farmacorresistencia Bacteriana/genética , Farmacorresistencia Microbiana/genética , Farmacorresistencia Microbiana/efectos de los fármacos
3.
Euro Surveill ; 29(26)2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38940004

RESUMEN

In 2022, an outbreak with severe bloodstream infections caused by Serratia marcescens occurred in an adult intensive care unit (ICU) in Hungary. Eight cases, five of whom died, were detected. Initial control measures could not stop the outbreak. We conducted a matched case-control study. In univariable analysis, the cases were more likely to be located around one sink in the ICU and had more medical procedures and medications than the controls, however, the multivariable analysis was not conclusive. Isolates from blood cultures of the cases and the ICU environment were closely related by whole genome sequencing and resistant or tolerant against the quaternary ammonium compound surface disinfectant used in the ICU. Thus, S. marcescens was able to survive in the environment despite regular cleaning and disinfection. The hospital replaced the disinfectant with another one, tightened the cleaning protocol and strengthened hand hygiene compliance among the healthcare workers. Together, these control measures have proved effective to prevent new cases. Our results highlight the importance of multidisciplinary outbreak investigations, including environmental sampling, molecular typing and testing for disinfectant resistance.


Asunto(s)
Infección Hospitalaria , Brotes de Enfermedades , Desinfectantes , Unidades de Cuidados Intensivos , Infecciones por Serratia , Serratia marcescens , Humanos , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Serratia marcescens/aislamiento & purificación , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Hungría/epidemiología , Infecciones por Serratia/epidemiología , Infecciones por Serratia/microbiología , Desinfectantes/farmacología , Estudios de Casos y Controles , Masculino , Femenino , Adulto , Persona de Mediana Edad , Secuenciación Completa del Genoma , Desinfección/métodos , Anciano , Control de Infecciones/métodos , Farmacorresistencia Bacteriana
4.
Int J Antimicrob Agents ; 64(2): 107257, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38914141

RESUMEN

OBJECTIVES: To describe the in vivo emergence of ceftazidime-avibactam resistance in GES-type carbapenemases and to characterize an unusual outbreak of GES-6-producing Serratia marcescens during the COVID-19 pandemic in Spain. METHODS: Retrospective study to describe a GES-CPSM outbreak based on whole genome sequencing and antimicrobial susceptibility testing (AST). Transferability of blaGES-carrying plasmid was assessed by conjugation experiments. RESULTS: In December 2020, we identified a cluster of S. marcescens harbouring blaGES-6 involving 9 patients. Whole-genome sequence analysis revealed a clonal relationship (≤3 SNPs) between the first isolates identified in each of the evolved patients and environmental samples with GES-CPSM detection. Plasmid analysis showed that the blaGES-6 gene was located in an IncQ3-type plasmid. Triparental mating experiments using a helper plasmid demonstrated mobilization of the blaGES-6-carrying plasmid. Our results also demonstrate within-host evolution in S. marcescens isolates, leading to a transition from blaGES-6 to the new blaGES-55, caused by the P162S mutation, in a subsequent infection in one of the affected patients. In blaGES-55 we identified emergence of ceftazidime-avibactam resistance along with an increase of carbapenems susceptibility. This patient had been treated with a 14-day course of ceftazidime-avibactam. AST of the transformants bearing blaGES-6 and blaGES-55 plasmids, confirmed susceptibility variation affecting ceftazidime-avibactam and carbapenems. CONCLUSIONS: We report an unusual outbreak of GES-6 whose incidence is becoming increasing. Transition from GES-6 to GES-55 may readily occur in vivo leading to ceftazidime-avibactam resistance, which brings to the fore the critical need for developing more accurate diagnosis tools for detection of GES ß-lactamases and optimise the use of antimicrobials.


Asunto(s)
Antibacterianos , Compuestos de Azabiciclo , Carbapenémicos , Ceftazidima , Brotes de Enfermedades , Combinación de Medicamentos , Pruebas de Sensibilidad Microbiana , Infecciones por Serratia , Serratia marcescens , beta-Lactamasas , Humanos , Ceftazidima/farmacología , Serratia marcescens/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/aislamiento & purificación , Compuestos de Azabiciclo/farmacología , Infecciones por Serratia/microbiología , Infecciones por Serratia/epidemiología , beta-Lactamasas/genética , beta-Lactamasas/metabolismo , Estudios Retrospectivos , Carbapenémicos/farmacología , Masculino , Antibacterianos/farmacología , Femenino , Persona de Mediana Edad , Plásmidos/genética , España/epidemiología , COVID-19/epidemiología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Secuenciación Completa del Genoma , Anciano , Farmacorresistencia Bacteriana Múltiple/genética
5.
J Infect Dev Ctries ; 18(5): 726-731, 2024 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-38865389

RESUMEN

INTRODUCTION: Serratia marcescens is an opportunistic pathogen found ubiquitously in the environment and associated with a wide range of nosocomial infections. This multidrug-resistant bacterium has been a cause of concern for hospitals and healthcare facilities due to its ability to spread rapidly and cause outbreaks. Next generation sequencing genotyping of bacterial isolates has proven to be a valuable tool for tracking the spread and transmission of nosocomial infections. This has allowed for the identification of outbreaks and transmission chains, as well as determining whether cases are due to endogenous or exogenous sources. Evidence of nosocomial transmission has been gathered through genotyping methods. The aim of this study was to investigate the genetic diversity of carbapenemase-producing S. marcescens in an outbreak at a public hospital in Cuiaba, MT, Brazil. METHODOLOGY: Ten isolates of S. marcenses were sequenced and antibiotic resistance profiles analyzed over 12 days. RESULTS: The isolates were clonal and multidrug resistant. Gentamycin and tigecycline had sensitivity in 90% and 80% isolates, respectively. Genomic analysis identified several genes that encode ß-lactamases, aminoglycoside-modifying enzymes, efflux pumps, and other virulence factors. CONCLUSIONS: Systematic surveillance is crucial in monitoring the evolution of S. marcescens genotypes, as it can lead to early detection and prevention of outbreaks.


Asunto(s)
Antibacterianos , Infección Hospitalaria , Brotes de Enfermedades , Farmacorresistencia Bacteriana Múltiple , Unidades de Cuidados Intensivos , Infecciones por Serratia , Serratia marcescens , Secuenciación Completa del Genoma , Serratia marcescens/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/aislamiento & purificación , Humanos , Brasil/epidemiología , Farmacorresistencia Bacteriana Múltiple/genética , Infecciones por Serratia/microbiología , Infecciones por Serratia/epidemiología , Infección Hospitalaria/microbiología , Infección Hospitalaria/epidemiología , Antibacterianos/farmacología , Pruebas de Sensibilidad Microbiana , Genotipo , Genoma Bacteriano , beta-Lactamasas/genética , Variación Genética
6.
PLoS One ; 19(6): e0304378, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38865328

RESUMEN

OBJECTIVE: Evaluate the effects of five disinfection methods on bacterial concentrations in hospital sink drains, focusing on three opportunistic pathogens (OPs): Serratia marcescens, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. DESIGN: Over two years, three sampling campaigns were conducted in a neonatal intensive care unit (NICU). Samples from 19 sink drains were taken at three time points: before, during, and after disinfection. Bacterial concentration was measured using culture-based and flow cytometry methods. High-throughput short sequence typing was performed to identify the three OPs and assess S. marcescens persistence after disinfection at the genotypic level. SETTING: This study was conducted in a pediatric hospitals NICU in Montréal, Canada, which is divided in an intensive and intermediate care side, with individual rooms equipped with a sink. INTERVENTIONS: Five treatments were compared: self-disinfecting drains, chlorine disinfection, boiling water disinfection, hot tap water flushing, and steam disinfection. RESULTS: This study highlights significant differences in the effectiveness of disinfection methods. Chlorine treatment proved ineffective in reducing bacterial concentration, including the three OPs. In contrast, all other drain interventions resulted in an immediate reduction in culturable bacteria (4-8 log) and intact cells (2-3 log). Thermal methods, particularly boiling water and steam treatments, exhibited superior effectiveness in reducing bacterial loads, including OPs. However, in drains with well-established bacterial biofilms, clonal strains of S. marcescens recolonized the drains after heat treatments. CONCLUSIONS: Our study supports thermal disinfection (>80°C) for pathogen reduction in drains but highlights the need for additional trials and the implementation of specific measures to limit biofilm formation.


Asunto(s)
Desinfección , Unidades de Cuidado Intensivo Neonatal , Serratia marcescens , Serratia marcescens/efectos de los fármacos , Desinfección/métodos , Humanos , Pseudomonas aeruginosa/efectos de los fármacos , Recién Nacido , Stenotrophomonas maltophilia/efectos de los fármacos , Infecciones por Serratia/microbiología , Infecciones por Serratia/prevención & control , Infección Hospitalaria/prevención & control , Infección Hospitalaria/microbiología
7.
J Hosp Infect ; 151: 69-78, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38740300

RESUMEN

BACKGROUND: The healthcare water environment is a potential reservoir of carbapenem-resistant organisms (CROs). AIM: To report the role of the water environment as a reservoir and the infection control measures applied to suppress a prolonged outbreak of Klebsiella pneumoniae carbapenemase-producing Serratia marcescens (KPC-SM) in two intensive care units (ICUs). METHODS: The outbreak occurred in the ICUs of a tertiary hospital from October 2020 to July 2021. Comprehensive patient contact tracing and environmental assessments were conducted, and a case-control study was performed to identify factors associated with the acquisition of KPC-SM. Associations among isolates were assessed via pulsed-field gel electrophoresis (PFGE). Antibiotic usage was analysed. FINDINGS: The outbreak consisted of two waves involving a total of 30 patients with KPC-SM. Multiple environmental cultures identified KPC-SM in a sink, a dirty utility room, and a communal bathroom shared by the ICUs, together with the waste bucket of a continuous renal replacement therapy (CRRT) system. The genetic similarity of the KPC-SM isolates from patients and the environment was confirmed by PFGE. A retrospective review of 30 cases identified that the use of CRRT and antibiotics was associated with acquisition of KPC-SM (P < 0.05). There was a continuous increase in the use of carbapenems; notably, the use of colistin has increased since 2019. CONCLUSION: Our study demonstrates that CRRT systems, along with other hospital water environments, are significant potential sources of resistant micro-organisms, underscoring the necessity of enhancing infection control practices in these areas.


Asunto(s)
Antibacterianos , Proteínas Bacterianas , Infección Hospitalaria , Brotes de Enfermedades , Unidades de Cuidados Intensivos , Infecciones por Serratia , Serratia marcescens , beta-Lactamasas , Humanos , Serratia marcescens/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/aislamiento & purificación , Serratia marcescens/enzimología , Infección Hospitalaria/microbiología , Infección Hospitalaria/epidemiología , Infecciones por Serratia/epidemiología , Infecciones por Serratia/microbiología , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Masculino , Estudios de Casos y Controles , beta-Lactamasas/metabolismo , beta-Lactamasas/genética , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Femenino , Anciano , Persona de Mediana Edad , Estudios Retrospectivos , Centros de Atención Terciaria , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/enzimología , Klebsiella pneumoniae/aislamiento & purificación , Microbiología del Agua , Control de Infecciones/métodos , Anciano de 80 o más Años , Adulto
8.
J Hosp Infect ; 150: 26-33, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38782059

RESUMEN

BACKGROUND: Serratia marcescens is known to cause outbreaks in neonatal intensive care units (NICUs). Traditionally epidemiological data, antimicrobial resistance patterns and epidemiological typing have been used to guide infection prevention methods. Whole-genome sequencing (WGS) applications such as core-genome multi-locus sequence typing (cgMLST) applied during an outbreak would potentially yield more information. AIM: To use cgMLST to acquire detailed information on the source and spread of bacteria, enabling more efficient control measures during an S. marcescens outbreak at a NICU. METHODS: Neonates admitted to the NICU of the Leiden University Medical Center (LUMC) during an outbreak between September 2023 and January 2024, with S. marcescens being cultured, were included. Environmental samples were taken to search for a common source, antibiotic susceptibility testing was performed, and antimicrobial resistance genes were analysed. FINDINGS: S. marcescens strains from 17 of the 20 positive patients were available for molecular typing. The cgMLST scheme revealed five different complex types consisting of four separate clusters. Multiple clusters made an unidentified persistent environmental source as cause of the outbreak less likely, leading to a quick downscaling of infection prevention measures. Differences were shown in aminoglycoside resistance patterns of isolates within the same complex types and patients. CONCLUSION: The use of ad-hoc cgMLST provided timely data for rational decision-making during an S. marcescens outbreak at the NICU. Antibiotic phenotyping alone was found not to be suitable for studying clonal spread during this outbreak with S. marcescens.


Asunto(s)
Infección Hospitalaria , Brotes de Enfermedades , Control de Infecciones , Unidades de Cuidado Intensivo Neonatal , Infecciones por Serratia , Serratia marcescens , Humanos , Serratia marcescens/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/clasificación , Serratia marcescens/aislamiento & purificación , Infecciones por Serratia/epidemiología , Infecciones por Serratia/microbiología , Recién Nacido , Control de Infecciones/métodos , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Infección Hospitalaria/prevención & control , Tipificación Molecular , Países Bajos/epidemiología , Pruebas de Sensibilidad Microbiana , Masculino , Tipificación de Secuencias Multilocus , Femenino , Secuenciación Completa del Genoma , Epidemiología Molecular
9.
Artículo en Inglés | MEDLINE | ID: mdl-38745416

RESUMEN

The photocatalytic technology for indoor air disinfection has been broadly studied in the last decade. Selecting proper photocatalysts with high disinfection efficiency remains to be a challenge. By doping with the incorporation of metals, the bandgap can be narrowed while avoiding the recombination of photogenerated charge. Three photocatalysts (Ag-TiO2, MnO2-TiO2, and MnS2-TiO2) were tested in photocatalytic sterilization process. The results revealed that Ag-TiO2 had the best antibacterial performance. Within 20 min, the concentration of Serratia marcescens (the tested bacteria) decreased log number of ln 4.04 under 640 w/m2 light intensity with 1000 µg/mL of Ag-TiO2. During the process of inactivating bacteria, the cell membranes of bacterial was destructed and thus decreasing the activity of enzymes and releasing the cell contents, due to the generation of reactive oxygen species (O2•- and •OH) and thermal effect. Spectral regulation has the greatest impact on the sterilization efficiency of MnO2-TiO2, which reduces the probability of photocatalytic materials being excited.


Asunto(s)
Contaminación del Aire Interior , Serratia marcescens , Titanio , Titanio/química , Contaminación del Aire Interior/prevención & control , Contaminación del Aire Interior/análisis , Catálisis , Serratia marcescens/efectos de los fármacos , Serratia marcescens/efectos de la radiación , Óxidos/química , Óxidos/farmacología , Nanoestructuras/química , Compuestos de Manganeso/química , Desinfección/métodos , Procesos Fotoquímicos , Plata/química , Plata/farmacología , Microbiología del Aire , Especies Reactivas de Oxígeno/metabolismo
10.
Chemosphere ; 361: 142487, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38821129

RESUMEN

This study unveils the detoxification potential of insecticide-tolerant plant beneficial bacteria (PBB), i.e., Ciceribacter azotifigens SF1 and Serratia marcescens SRB1, in spinach treated with fipronil (FIP), profenofos (PF) and chlorantraniliprole (CLP) insecticides. Increasing insecticide doses (25-400 µg kg-1 soil) significantly curtailed germination attributes and growth of spinach cultivated at both bench-scale and in greenhouse experiments. Profenofos at 400 µg kg-1 exhibited maximum inhibitory effects and reduced germination by 55%; root and shoot length by 78% and 81%, respectively; dry matter accumulation in roots and shoots by 79% and 62%, respectively; leaf number by 87% and leaf area by 56%. Insecticide application caused morphological distortion in root tips/surfaces, increased levels of oxidative stress, and cell death in spinach. Application of insecticide-tolerant SF1 and SRB1 strains relieved insecticide pressure resulting in overall improvement in growth and physiology of spinach grown under insecticide stress. Ciceribacter azotifigens improved germination rate (10%); root biomass (53%); shoot biomass (25%); leaf area (10%); Chl-a (45%), Chl-b (36%) and carotenoid (48%) contents of spinach at 25 µg CLP kg-1 soil. PBB inoculation reinvigorated the stressed spinach and modulated the synthesis of phytochemicals, proline, malondialdehyde (MDA), superoxide anions (O2•-), and hydrogen peroxide (H2O2). Scanning electron microscopy (SEM) revealed recovery in root tip morphology and stomatal openings on abaxial leaf surfaces of PBB-inoculated spinach grown with insecticides. Ciceribacter azotifigens inoculation significantly increased intrinsic water use efficiency, transpiration rate, vapor pressure deficit, intracellular CO2 concentration, photosynthetic rate, and stomatal conductance in spinach exposed to 25 µg FIP kg-1. Also, C. azotifigens and S. marcescens modulated the antioxidant defense systems of insecticide-treated spinach. Bacterial strains were strongly colonized to root surfaces of insecticide-stressed spinach seedlings as revealed under SEM. The identification of insecticide-tolerant PBBs such as C. azotifigens and S. marcescens hold the potential for alleviating abiotic stress to spinach, thereby fostering enhanced and safe production within polluted agroecosystems.


Asunto(s)
Antioxidantes , Insecticidas , Hojas de la Planta , Raíces de Plantas , Serratia marcescens , Contaminantes del Suelo , Spinacia oleracea , Spinacia oleracea/efectos de los fármacos , Spinacia oleracea/fisiología , Spinacia oleracea/metabolismo , Contaminantes del Suelo/toxicidad , Contaminantes del Suelo/metabolismo , Raíces de Plantas/efectos de los fármacos , Raíces de Plantas/microbiología , Hojas de la Planta/efectos de los fármacos , Serratia marcescens/fisiología , Serratia marcescens/efectos de los fármacos , Serratia marcescens/metabolismo , Antioxidantes/metabolismo , Insecticidas/toxicidad , Plaguicidas/metabolismo , Plaguicidas/toxicidad , Biodegradación Ambiental , Estrés Oxidativo/efectos de los fármacos , Bacillaceae/metabolismo , Bacillaceae/fisiología , Fotosíntesis/efectos de los fármacos , Microbiología del Suelo , Suelo/química , Germinación/efectos de los fármacos
11.
Nat Commun ; 15(1): 3947, 2024 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-38729951

RESUMEN

Gram-negative bacteria (GNB) are a major cause of neonatal sepsis in low- and middle-income countries (LMICs). Although the World Health Organization (WHO) reports that over 80% of these sepsis deaths could be prevented through improved treatment, the efficacy of the currently recommended first- and second-line treatment regimens for this condition is increasingly affected by high rates of drug resistance. Here we assess three well known antibiotics, fosfomycin, flomoxef and amikacin, in combination as potential antibiotic treatment regimens by investigating the drug resistance and genetic profiles of commonly isolated GNB causing neonatal sepsis in LMICs. The five most prevalent bacterial isolates in the NeoOBS study (NCT03721302) are Klebsiella pneumoniae, Acinetobacter baumannii, E. coli, Serratia marcescens and Enterobacter cloacae complex. Among these isolates, high levels of ESBL and carbapenemase encoding genes are detected along with resistance to ampicillin, gentamicin and cefotaxime, the current WHO recommended empiric regimens. The three new combinations show excellent in vitro activity against ESBL-producing K. pneumoniae and E. coli isolates. Our data should further inform and support the clinical evaluation of these three antibiotic combinations for the treatment of neonatal sepsis in areas with high rates of multidrug-resistant Gram-negative bacteria.


Asunto(s)
Acinetobacter baumannii , Antibacterianos , Bacterias Gramnegativas , Infecciones por Bacterias Gramnegativas , Klebsiella pneumoniae , Pruebas de Sensibilidad Microbiana , Sepsis Neonatal , Humanos , Antibacterianos/uso terapéutico , Antibacterianos/farmacología , Sepsis Neonatal/microbiología , Sepsis Neonatal/tratamiento farmacológico , Recién Nacido , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/genética , Bacterias Gramnegativas/aislamiento & purificación , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/microbiología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/aislamiento & purificación , Acinetobacter baumannii/genética , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/aislamiento & purificación , Klebsiella pneumoniae/genética , Amicacina/farmacología , Amicacina/uso terapéutico , Fosfomicina/farmacología , Fosfomicina/uso terapéutico , beta-Lactamasas/genética , beta-Lactamasas/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Países en Desarrollo , Farmacorresistencia Bacteriana Múltiple/genética , Quimioterapia Combinada , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Serratia marcescens/aislamiento & purificación , Enterobacter cloacae/efectos de los fármacos , Enterobacter cloacae/genética , Enterobacter cloacae/aislamiento & purificación , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo
12.
Int J Antimicrob Agents ; 63(5): 107149, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38508537

RESUMEN

OBJECTIVES: blaKPC-carrying Enterobacterales have post great challenges to global healthcare systems. In this study, we reported the evolution and spread of blaKPC between Serratia marcescens and Klebsiella pneumoniae. METHODS: Four S. marcescens and one K. pneumoniae strains were isolated from the sputum samples of the patient. Antimicrobial susceptibility tests and whole genome sequencing were performed to investigate the phenotype & genotype of strains. Conjugation assays, cloning experiment and kinetic parameters measuring were performed to explore the spread and antimicrobial resistance mechanisms. RESULTS: The evolution and transmission of blaKPC-2 occurred during the treatment of ceftazidime-avibactam and trimethoprim-sulfamethoxazole. Analysis of the antimicrobial susceptibility and genetic profiles of the clinical strains showed that blaKPC-2 evolved into blaKPC-71 and blaKPC-44, together with resistance to ceftazidime-avibactam and carbapenems susceptibility recovery under antimicrobial pressure. Cloning and expression of blaKPC-44 & blaKPC-71 in E. coli DH5α showed that KPC-44 and KPC-71 resulted in a 64∼128-fold increase in the MIC value for ceftazidime-avibactam. Meanwhile, the kinetic assays also showed that the enzyme activity of KPC-44 and KPC-71 towards carbapenems was destroyed and couldn't be inhibited by avibactam. Based on the conjugation assay and whole genome sequence analyses, we provided evolutionary insights into the transmission pathway trace of blaKPC-bearing plasmids between S. marcescens and K. pneumoniae. CONCLUSIONS: Mixed-species co-infection is one of the risk factors leading to the spread of plasmids carrying carbapenem-resistant genes, and increased surveillance of multidrug-resistant Enterobacterales is urgently needed.


Asunto(s)
Antibacterianos , Infecciones por Klebsiella , Klebsiella pneumoniae , Pruebas de Sensibilidad Microbiana , Plásmidos , Infecciones por Serratia , Serratia marcescens , Secuenciación Completa del Genoma , beta-Lactamasas , Serratia marcescens/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/aislamiento & purificación , Serratia marcescens/enzimología , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/efectos de los fármacos , Humanos , Plásmidos/genética , beta-Lactamasas/genética , Infecciones por Serratia/microbiología , Infecciones por Serratia/epidemiología , Antibacterianos/farmacología , Infecciones por Klebsiella/microbiología , Infecciones por Klebsiella/epidemiología , Ceftazidima/farmacología , Combinación de Medicamentos , Farmacorresistencia Bacteriana Múltiple/genética , Compuestos de Azabiciclo/farmacología , Esputo/microbiología , Evolución Molecular , Transferencia de Gen Horizontal , Carbapenémicos/farmacología
13.
Biotechnol Lett ; 43(12): 2243-2257, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34652635

RESUMEN

The biopreservation strategy allows extending the shelf life and food safety through the use of indigenous or controlled microbiota and their antimicrobial compounds. The aim of this work was to characterize an inhibitory substance with bacteriocin-like activity (Sak-59) produced by the potentially probiotic L. sakei strain from artisanal traditional Kazakh horse meat product Kazy. The maximum production of Sak-59 occurred at the stationary phase of the L. sakei growth. Sak-59 showed inhibitory activity against gram-positive meat spoilage bacteria strains of Listeria monocytogenes, Staphylococcus aureus, and pathogenic gram-negative bacteria strains of Serratia marcescens and Escherichia coli, but not against the tested Lactobacilli strains. Sak-59 activity, as measured by diffusion assay in agar wells, was completely suppressed after treatment with proteolytic enzymes and remained stable after treatment with α-amylase and lipase, indicating that Sak-59 is a peptide and most likely not glycosylated or lipidated. It was concluded that Sak-59 is a potential new bacteriocin with a characteristic activity spectrum, which can be useful in the food and feed industries.


Asunto(s)
Bacteriocinas/genética , Microbiología de Alimentos , Latilactobacillus sakei/química , Productos de la Carne/microbiología , Animales , Antibacterianos/química , Antibacterianos/farmacología , Bacteriocinas/aislamiento & purificación , Bacteriocinas/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/patogenicidad , Almacenamiento de Alimentos , Caballos/microbiología , Humanos , Latilactobacillus sakei/genética , Péptidos/química , Péptidos/farmacología , Serratia marcescens/efectos de los fármacos , Serratia marcescens/patogenicidad , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/patogenicidad
14.
Antimicrob Agents Chemother ; 65(12): e0078621, 2021 11 17.
Artículo en Inglés | MEDLINE | ID: mdl-34491801

RESUMEN

Serratia marcescens, a member of the order Enterobacterales, is adept at colonizing health care environments and is an important cause of invasive infections. Antibiotic resistance is a daunting problem in S. marcescens because, in addition to plasmid-mediated mechanisms, most isolates have considerable intrinsic resistance to multiple antibiotic classes. To discover endogenous modifiers of antibiotic susceptibility in S. marcescens, a high-density transposon insertion library was subjected to sub-MICs of two cephalosporins, cefoxitin, and cefepime, as well as the fluoroquinolone ciprofloxacin. Comparisons of transposon insertion abundance before and after antibiotic exposure identified hundreds of potential modifiers of susceptibility to these agents. Using single-gene deletions, we validated several candidate modifiers of cefoxitin susceptibility and chose ydgH, a gene of unknown function, for further characterization. In addition to cefoxitin, deletion of ydgH in S. marcescens resulted in decreased susceptibility to multiple third-generation cephalosporins and, in contrast, to increased susceptibility to both cationic and anionic detergents. YdgH is highly conserved throughout the Enterobacterales, and we observed similar phenotypes in Escherichia coli O157:H7 and Enterobacter cloacae mutants. YdgH is predicted to localize to the periplasm, and we speculate that it may be involved there in cell envelope homeostasis. Collectively, our findings provide insight into chromosomal mediators of antibiotic resistance in S. marcescens and will serve as a resource for further investigations of this important pathogen.


Asunto(s)
Antibacterianos , Serratia marcescens , Antibacterianos/farmacología , Cefalosporinas/farmacología , Detergentes/farmacología , Farmacorresistencia Bacteriana , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética
15.
FEMS Microbiol Lett ; 368(14)2021 07 20.
Artículo en Inglés | MEDLINE | ID: mdl-34264334

RESUMEN

Serratia marcescens SCH909 is a multidrug resistant strain isolated in 1988 harboring three class 1 integrons. We wondered if these integrons were retained over time and if there were other antimicrobial resistant determinants contributing to its multidrug resistant profile. Genomic analysis showed a fourth multidrug resistance integron, a Tn7 transposon with dfrA1-sat2-ybeA-ybfA-ybfB-ybgA gene cassettes in the variable region. Insertion sequences were involved in the genesis of novel composite transposons in the L4 subtype plasmid pSCH909, such as Tn6824 carrying an arsenic regulon and two head to head class 1 integrons surrounded by two complete IS1. Remarkably, a novel chromosomal genomic island, SmaR, was identified, closely related to Multiple Antimicrobial Resistance Regions (MARR), usually found in AbaR0-type and AbGRI2-0 from global clones of Acinetobacter baumannii, and in M-type plasmids circulating in Enterobacteriaceae. Maintenance studies showed that the three class 1 integrons were maintained over 1 month without antimicrobial pressure. Since S. marcescens is considered a relevant nosocomial pathogen that can have a wide range of niches - human, plant, animal, soil and inanimate surfaces, our findings support the ability of this species to capture, maintain and spread a broad variety of antimicrobial resistance elements.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Acinetobacter baumannii/genética , Animales , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Enterobacteriaceae/genética , Genes Bacterianos , Genoma Bacteriano/genética , Islas Genómicas/genética , Humanos , Integrones/genética , Plásmidos/genética , Serratia marcescens/aislamiento & purificación
16.
Sci Rep ; 11(1): 13230, 2021 06 24.
Artículo en Inglés | MEDLINE | ID: mdl-34168215

RESUMEN

Colistin resistance is complex and multifactorial. DbcA is an inner membrane protein belonging to the DedA superfamily required for maintaining extreme colistin resistance of Burkholderia thailandensis. The molecular mechanisms behind this remain unclear. Here, we report that ∆dbcA displays alkaline pH/bicarbonate sensitivity and propose a role of DbcA in extreme colistin resistance of B. thailandensis by maintaining cytoplasmic pH homeostasis. We found that alkaline pH or presence of sodium bicarbonate displays a synergistic effect with colistin against not only extremely colistin resistant species like B. thailandensis and Serratia marcescens, but also a majority of Gram-negative and Gram-positive bacteria tested, suggesting a link between cytoplasmic pH homeostasis and colistin resistance across species. We found that lowering the level of oxygen in the growth media or supplementation of fermentable sugars such as glucose not only alleviated alkaline pH stress, but also increased colistin resistance in most bacteria tested, likely by avoiding cytoplasmic alkalinization. Our observations suggest a previously unreported link between pH, oxygen, and colistin resistance. We propose that maintaining optimal cytoplasmic pH is required for colistin resistance in a majority of bacterial species, consistent with the emerging link between cytoplasmic pH homeostasis and antibiotic resistance.


Asunto(s)
Colistina/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Farmacorresistencia Bacteriana/fisiología , Homeostasis/fisiología , Antibacterianos/farmacología , Proteínas Bacterianas/efectos de los fármacos , Proteínas Bacterianas/metabolismo , Burkholderia/efectos de los fármacos , Burkholderia/fisiología , Medios de Cultivo/metabolismo , Concentración de Iones de Hidrógeno , Proteínas de la Membrana/metabolismo , Pruebas de Sensibilidad Microbiana , Serratia marcescens/efectos de los fármacos , Serratia marcescens/fisiología
17.
Braz J Microbiol ; 52(3): 1341-1345, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33829377

RESUMEN

The occurrence of multidrug-resistant Serratia marcescens strains represents a serious public health threat. The purpose here is to report three cases of carbapenem-resistant S. marcescens infections with unfavorable clinical outcomes and provide a molecular description of the antibiotic resistance determinants at a genomic level. We performed bacterial identification by VITEK 2 and MALDI-TOF. The minimal inhibitory concentrations of antimicrobials were determined according to the Clinical and Laboratory Standards Institute guidelines, except for tigecycline, for which they were determined using Etest strips. Preliminary screening for the presence of carbapenemases was performed by ertapenem hydrolysis using MALDI-TOF MS. Whole-genome sequencing was provided to identify genes responsible for virulence and antimicrobial resistance. Here we report three challenging cases of S. marcescens that were resistant to the most commonly used antibiotics. Otherwise, we performed a genome description, which includes several genes involved in the resistance and virulence. These cases illustrate serious infection due to multidrug-resistant organisms and the complexity of treatment. Our results highlight the need to evaluate isolates regularly during long-term hospital stay to achieve optimal quality of clinical care and thus improve patient outcomes.


Asunto(s)
Antibacterianos , Farmacorresistencia Bacteriana Múltiple , Serratia marcescens , Antibacterianos/uso terapéutico , Carbapenémicos , Genoma Bacteriano , Humanos , Unidades de Cuidados Intensivos , Pruebas de Sensibilidad Microbiana , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Virulencia , Secuenciación Completa del Genoma
18.
mSphere ; 6(2)2021 03 10.
Artículo en Inglés | MEDLINE | ID: mdl-33692192

RESUMEN

Serratia marcescens is an emerging pathogen with increasing clinical importance due to its intrinsic resistance to several classes of antibiotics. The chromosomally encoded drug efflux pumps contribute to antibiotic resistance and represent a major challenge for the treatment of bacterial infections. The ABC-type efflux pump MacAB was previously linked to macrolide resistance in Escherichia coli and Salmonella enterica serovar Typhimurium. The role of the MacAB homolog in antibiotic resistance of S. marcescens is currently unknown. We found that an S. marcescens mutant lacking the MacAB pump did not show increased sensitivity to the macrolide antibiotic erythromycin but was significantly more sensitive to aminoglycoside antibiotics and polymyxins. We also showed that, in addition to its role in drug efflux, the MacAB efflux pump is required for swimming motility and biofilm formation. We propose that the motility defect of the ΔmacAB mutant is due, at least in part, to the loss of functional flagella on the bacterial surface. Furthermore, we found that the promoter of the MacAB efflux pump was active during the initial hours of growth in laboratory medium and that its activity was further elevated in the presence of hydrogen peroxide. Finally, we demonstrate a complete loss of ΔmacAB mutant viability in the presence of peroxide, which is fully restored by complementation. Thus, the S. marcescens MacAB efflux pump is essential for survival during oxidative stress and is involved in protection from polymyxins and aminoglycoside antibiotics.IMPORTANCE The opportunistic pathogen Serratia marcescens can cause urinary tract infections, respiratory infections, meningitis, and sepsis in immunocompromised individuals. These infections are challenging to treat due to the intrinsic resistance of S. marcescens to an extensive array of antibiotics. Efflux pumps play a crucial role in protection of bacteria from antimicrobials. The MacAB efflux pump, previously linked to efflux of macrolides in Escherichia coli and protection from oxidative stress in Salmonella enterica serovar Typhimurium, is not characterized in S. marcescens We show the role of the MacAB efflux pump in S. marcescens protection from aminoglycoside antibiotics and polymyxins, modulation of bacterial motility, and biofilm formation, and we illustrate the essential role for this pump in bacterial survival during oxidative stress. Our findings make the MacAB efflux pump an attractive target for inhibition to gain control over S. marcescens infections.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Aminoglicósidos/farmacología , Antibacterianos/farmacología , Proteínas Bacterianas/metabolismo , Estrés Oxidativo , Polimixinas/farmacología , Serratia marcescens/efectos de los fármacos , Serratia marcescens/genética , Transportadoras de Casetes de Unión a ATP/genética , Proteínas Bacterianas/genética , Farmacorresistencia Bacteriana Múltiple , Serratia marcescens/metabolismo
19.
Braz J Microbiol ; 52(2): 627-638, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33686563

RESUMEN

BACKGROUND: Serratia marcescens becomes an apparent nosocomial pathogen and causes a variety of infections. S. marcescens possess various virulence factors that are regulated by intercellular communication system quorum sensing (QS). Targeting bacterial virulence is a proposed strategy to overcome bacterial resistance. Sitagliptin anti-QS activity has been demonstrated previously and we aimed in this study to investigate the effects of antidiabetic drugs vildagliptin and metformin compared to sitagliptin on S. marcescens pathogenesis. METHODS: We assessed the effects of tested drugs in subinhibitory concentrations phenotypically on the virulence factors and genotypically on the virulence encoding genes' expressions. The protection of tested drugs on S. marcescens pathogenesis was performed in vivo. Molecular docking study has been conducted to evaluate the interference capabilities of tested drugs to the SmaR QS receptor. RESULTS: Vildagliptin reduced the expression of virulence encoding genes but did not show in vitro or in vivo anti-virulence activities. Metformin reduced the expression of virulence encoding genes and inhibited bacterial virulence in vitro but did not show in vivo protection. Sitagliptin significantly inhibited virulence factors in vitro, reduced the expression of virulence factors and protected mice from S. marcescens. Docking study revealed that sitagliptin is more active than metformin and fully binds to SmaR receptor, whereas vildagliptin had single interaction to SmaR. CONCLUSION: The downregulation of virulence genes was not enough to show anti-virulence activities. Hindering of QS receptors may play a crucial role in diminishing bacterial virulence.


Asunto(s)
Antibacterianos/farmacología , Reposicionamiento de Medicamentos , Hipoglucemiantes/farmacología , Infecciones por Serratia/tratamiento farmacológico , Serratia marcescens/efectos de los fármacos , Animales , Antibacterianos/química , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Femenino , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Humanos , Hipoglucemiantes/química , Metformina/química , Metformina/farmacología , Ratones , Simulación del Acoplamiento Molecular , Infecciones por Serratia/microbiología , Serratia marcescens/genética , Serratia marcescens/patogenicidad , Serratia marcescens/fisiología , Vildagliptina/química , Vildagliptina/farmacología , Virulencia/efectos de los fármacos , Factores de Virulencia/química , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
20.
Biomolecules ; 11(2)2021 01 30.
Artículo en Inglés | MEDLINE | ID: mdl-33573343

RESUMEN

Green synthesis of metal nanoparticles using plant extracts as capping and reducing agents for the biomedical applications has received considerable attention. Moreover, emergence and spread of multidrug resistance among bacterial pathogens has become a major health concern and lookout for novel alternative effective drugs has gained momentum. In current study, we synthesized gold nanoparticles using the seed extract of Trachyspermum ammi (TA-AuNPs), assessed its efficacy against drug resistant biofilms of Listeria monocytogenes and Serratia marcescens, and evaluated its anticancer potential against HepG2 cancer cell lines. Microwave-assisted green synthesis of gold nanoparticles was carried out and characterization was done using UV-vis spectroscopy, X-ray diffraction (XRD), transmission electron microscopy (TEM), and dynamic light scattering (DLS). Most nanoparticles were observed as spherical and spheroidal with few anisotropies with an average crystalline size of 16.63 nm. Synthesized TA-AuNPs demonstrated significant biofilm inhibitory activity against L. monocytogenes (73%) as well as S. marcescens (81%). Exopolysaccharide (EPS), motility, and CSH, key elements that facilitate the formation and maintenance of biofilm were also inhibited significantly at the tested sub-minimum inhibitory concentrations (sub-MICs). Further, TA-AuNPs effectively obliterated preformed mature biofilms of S. marcescens and L. monocytogenes by 64% and 58%, respectively. Induction of intracellular ROS production in TA-AuNPs treated bacterial cells could be the plausible mechanism for the reduced biofilm formation in test pathogens. Administration of TA-AuNPs resulted in the arrest of cellular proliferation in a concentration-dependent manner. TA-AuNPs decrease the intracellular GSH in HepG2 cancer cell lines, cells become more prone to ROS generation, hence induce apoptosis. Thus, this work proposes a new eco-friendly and rapid approach for fabricating NPs which can be exploited for multifarious biomedical applications.


Asunto(s)
Antineoplásicos/farmacología , Apiaceae/metabolismo , Oro/química , Nanopartículas del Metal/química , Especies Reactivas de Oxígeno , Semillas/metabolismo , Anisotropía , Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Supervivencia Celular , Glutatión Transferasa/metabolismo , Tecnología Química Verde , Células Hep G2 , Humanos , Luz , Peroxidación de Lípido , Listeria monocytogenes/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Microscopía Electrónica de Transmisión , Microondas , Extractos Vegetales/farmacología , Polisacáridos Bacterianos/química , Dispersión de Radiación , Serratia marcescens/efectos de los fármacos , Sales de Tetrazolio/química , Tiazoles/química , Difracción de Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...